Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis. - Wikidata - awgldk - TriplyDB

Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis.

Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis.

http://www.wikidata.org/entity/Q37142814

about

Group III secreted phospholipase A2 regulates epididymal sperm maturation and fertility in mice.Bee Venom Phospholipase A2: Yesterday's Enemy Becomes Today's Friend Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention Oleoyl-lysophosphatidylcholine limits endothelial nitric oxide bioavailability by induction of reactive oxygen species Enhanced Phospholipase A2 Group 3 Expression by Oxidative Stress Decreases the Insulin-Degrading Enzyme Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2-DP1 receptor paracrine axis The adipocyte-inducible secreted phospholipases PLA2G5 and PLA2G2E play distinct roles in obesity Association between dairy intake, lipids and vascular structure and function in diabetes The (G>A) rs11573191 polymorphism of PLA2G5 gene is associated with premature coronary artery disease in the Mexican Mestizo population: the genetics of atherosclerotic disease Mexican study.Bioactive products generated by group V sPLA(2) hydrolysis of LDL activate macrophages to secrete pro-inflammatory cytokines.Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease Acyl chain-dependent effect of lysophosphatidylcholine on endothelial prostacyclin production Varespladib methyl in cardiovascular disease.Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancer Hair follicular expression and function of group X secreted phospholipase A2 in mouse skin.Physiological roles of group X-secreted phospholipase A2 in reproduction, gastrointestinal phospholipid digestion, and neuronal function.Acyl chain-dependent effect of lysophosphatidylcholine on endothelium-dependent vasorelaxation Integrated lipidomics in the secreted phospholipase A(2) biology.Association between polymorphisms in phospholipase A2 genes and the plasma triglyceride response to an n-3 PUFA supplementation: a clinical trial Secretory phospholipase A₂ responsive liposomes.In vitro anti-Plasmodium falciparum properties of the full set of human secreted phospholipases A2.A new era of secreted phospholipase A₂ Acyl chain-dependent effect of lysophosphatidylcholine on cyclooxygenase (COX)-2 expression in endothelial cells.Thyroid hormone status regulates the expression of secretory phospholipases Neutrophil effector responses are suppressed by secretory phospholipase A2 modified HDL.Group X Secreted Phospholipase A2 Releases ω3 Polyunsaturated Fatty Acids, Suppresses Colitis, and Promotes Sperm Fertility Syndecan-4 mediates macrophage uptake of group V secretory phospholipase A2-modified LDL.Molecular and functional characterization of polymorphisms in the secreted phospholipase A2 group X gene: relevance to coronary artery disease Group III secreted phospholipase A2 transgenic mice spontaneously develop inflammation The vicious circle between oxidative stress and inflammation in atherosclerosis.The capacity of group V sPLA2 to increase atherogenicity of ApoE-/- and LDLR-/- mouse LDL in vitro predicts its atherogenic role in vivo.Secreted phospholipase A2, lipoprotein hydrolysis, and atherosclerosis: integration with lipidomics Molecular biology of atherosclerosis.Secretory phospholipase A2 group IIA modulates insulin sensitivity and metabolism.Oligomeric amyloid-beta induces MAPK-mediated activation of brain cytosolic and calcium-independent phospholipase A2 in a spatial-specific manner.Group III phospholipase A2 promotes colitis and colorectal cancer.Phospholipase A2 inhibitors in the treatment of atherosclerosis: a new approach moves forward in the clinic.Expression and localization of sPLA2-III in the rat CNS.Metabolic regulation by secreted phospholipase A2.Lp-PLA2 et sPLA2

P2860

Q24631144-2AE9AC6F-3894-454C-B2B0-9683E7E4C161 Q26767063-BB88D4B3-84EC-4A88-8715-199D32041EF0 Q26997377-97A4BC94-A3A6-43C6-97EC-0A5EFAD1D33D Q27324083-DB68FB6C-728D-4604-8FD9-9E6A53F260C6 Q27340023-335CD09A-9CFF-40F2-843F-65ED08491A46 Q28510556-DDBFF907-FF44-42C4-B2F9-B3A749D35250 Q28586195-47DBA51F-5B32-4400-88AD-5B3A9EE69C87 Q33706757-9993A603-1A84-4814-AF7D-794FF3F7F2A8 Q33736168-3AB3D316-AD3A-4204-BC6F-FB3D44298693 Q33771533-E198E1BD-7270-4F33-8821-E5F308E9F4EA Q33923169-F2235008-67C6-4319-B82F-559F7522D736 Q34116412-5A52226A-DED4-4FFD-8728-F2D0B8E1257C Q34135420-D0D2FC56-3613-459D-B7FC-EEB0D340716A Q34182618-664B16EF-E099-4A90-9CDB-45603D29C107 Q34719753-3DF34674-B605-423E-B6A7-61C91580B3E5 Q34719758-5775D0B0-3DB2-472E-B2D0-6013A4646C69 Q34761280-94C5F846-6264-42D3-A96C-B6737E779D1F Q35036028-4B9CC00A-A67D-42BB-A1FE-6BC7A42B6D89 Q35125145-B4BF3028-EBD5-4F03-81D1-5A4347AF9389 Q35385515-F4098085-6011-43AE-9375-D11A4851EBD8 Q35590666-78439726-5C8A-4B3D-A40C-888579B3CEB4 Q35776615-5B6C75F8-BD65-4A31-A6EE-58138D594D46 Q36301300-A5B91DBA-E995-4297-9106-B3D5C96240A8 Q36394788-9E21BA89-321A-46B4-818A-C0424E3D223C Q36681188-541C9B69-07F2-4507-88D5-A1F383BB50CC Q36727399-6DA3FF0F-643E-4102-8499-62E69C60D70A Q37130793-3CA16A04-315C-47ED-BB1D-FA67FC12CBC0 Q37238669-822518BD-ECBC-48C8-944C-7573DD21224C Q37257483-E63C871E-2C14-47DF-B3CB-EE810842A0D6 Q37334949-BCD19432-84EB-4A75-810E-DCAAFDCCECB3 Q37435082-630F88A3-37AF-47E5-9FA9-4B35975CD52A Q37858911-31CF200F-11E5-4F9D-8C1E-9D2AB8037319 Q38125279-731C423B-EB8F-46C0-BB50-FD15D86CFE9A Q38701624-71754892-7F1C-44C8-8FD5-1F5109A7261C Q41149645-92DD444D-A9B8-444D-ACAE-D37CEC51E564 Q42363727-9876559D-729F-48AF-9716-672C328A69D2 Q43289695-0A90EE74-E804-49C8-A452-36D8DE6E488A Q45728856-9EDB9327-A02F-44FB-9CBF-A1E66D0A7097 Q47128368-EC868C36-05C8-4705-B730-34CAC85E9A16 Q58148425-760CF909-79C2-4096-AD0E-205EA24796B5

P2860

Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis.

http://www.wikidata.org/entity/Q37142814

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 September 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Analyses of group III secreted ...... ormation, and atherosclerosis.

@en

Analyses of group III secreted ...... ormation, and atherosclerosis.

@nl

type

label

Analyses of group III secreted ...... ormation, and atherosclerosis.

@en

Analyses of group III secreted ...... ormation, and atherosclerosis.

@nl

prefLabel

Analyses of group III secreted ...... ormation, and atherosclerosis.

@en

Analyses of group III secreted ...... ormation, and atherosclerosis.

@nl

P1433

Q37142814-4B7E72FC-54B9-48BF-A561-6AC0D502B1F3

P1476

Q37142814-CBFC6B7E-88DC-4AA0-8181-733946C4682A

P2093

Q37142814-033AE119-509D-4266-A98E-DA18308DE1D6

Q37142814-0CBE0BE9-F322-4816-A975-EA033E9A2C88

Q37142814-0D8E2BE4-0645-43B8-9740-735CB513E7D0

Q37142814-11D3D2DF-78D1-4852-A990-63BE2B651DFB

Q37142814-19A10169-5F4B-414B-BB6C-0A50C22BB965

Q37142814-224BB809-128A-429D-9999-3ECA43436CEE

Q37142814-290B0899-7C10-4FA8-8DCC-ED7D09B7E39B

Q37142814-37949B4B-373C-4E47-AF42-5B4CCC281BE7

Q37142814-7A8C8C8F-F298-4C21-A43A-80AD5C966AF7

Q37142814-7C445E54-35A6-4EFC-AA29-F700300506FF

P2860

Q37142814-049BD3F7-83B9-439B-82E6-A251223A7A7C

Q37142814-06202800-8FBB-4D14-B08B-F2D266E1C590

Q37142814-0667FD66-CC4F-4003-B3BE-F843390A57D1

Q37142814-07A86293-10BC-49FD-9DE5-0012F1FBE673

Q37142814-0A579E1D-31A0-4963-AA7A-C735D64185DC

Q37142814-0D310A34-4435-49A6-B5AF-26B977DC2719

Q37142814-1AB05293-7552-4048-8F0B-F5E224CC4CDF

Q37142814-2469B586-E5EC-4FD2-B991-370E897B54A9

Q37142814-2B7AEABD-D52B-4F94-8FE8-BCFD3B099D63

Q37142814-2FDFA257-C43F-4502-943D-00E0E43130D6

P304

Q37142814-24F41F47-6757-41EE-AB18-403BC9CFFD45

P31

Q37142814-CEFC019B-9AD5-4A50-8D73-76F64F2422FD

P356

Q37142814-E60C5D73-51EF-4A92-B45A-A4EB97CABEB5

P407

Q37142814-2AB82A99-E063-456C-9252-9BD65D55F8FB

P433

Q37142814-CAAD859C-840F-428E-B193-49F72D444E47

P478

Q37142814-CADFA3AC-2A98-4C1C-A59E-4D9FFECBE554

P50

Q37142814-5A063BF9-3845-4D8D-B4B8-4827B3E0B931

P577

Q37142814-132BDE77-DCF7-452A-837F-FA2668D7A7BA

P698

Q37142814-EA30CCF5-69D0-41C2-94B3-847EB4B66194

P921

Q37142814-89638944-EB7E-43B9-8908-61EB108ED3C5

Q37142814-8BDF8CBB-1CD1-4D45-A00E-4AFEA5045496

Q37142814-E835266A-0590-4D63-BFC6-D0639401F721

P932

Q37142814-858EAC36-7615-4E54-91AA-241C7D4D2A32

P356

P1433

Journal of Biological Chemistry

P1476

Analyses of group III secreted ...... formation, and atherosclerosis

@en

P2093

Go-ichi Saka

http://www.w3.org/2001/XMLSchema#string

Hiroyasu Sato

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Itabe

http://www.w3.org/2001/XMLSchema#string

Ichiro Kudo

http://www.w3.org/2001/XMLSchema#string

Joe Yamada

http://www.w3.org/2001/XMLSchema#string

Kae Tsutsumi

http://www.w3.org/2001/XMLSchema#string

Kazutaka Ikeda

http://www.w3.org/2001/XMLSchema#string

Kei Yamamoto

http://www.w3.org/2001/XMLSchema#string

Makoto Murakami

http://www.w3.org/2001/XMLSchema#string

Mitsuhiro Ohtsuki

http://www.w3.org/2001/XMLSchema#string

P2860

Novel human secreted phospholipase A(2) with homology to the group III bee venom enzyme

Macrophage secretory phospholipase A2 group X enhances anti-inflammatory responses, promotes lipid accumulation, and contributes to aberrant lung pathology

Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

Efficient selection for high-expression transfectants with a novel eukaryotic vector

Expression and characterization of human group V phospholipase A2

Binding of human phospholipase A2 type II to proteoglycans. Differential effect of glycosaminoglycans on enzyme activity

Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor

Distinct arachidonate-releasing functions of mammalian secreted phospholipase A2s in human embryonic kidney 293 and rat mastocytoma RBL-2H3 cells through heparan sulfate shuttling and external plasma membrane mechanisms

The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2

P304

33483-33497

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M804628200

http://www.w3.org/2001/XMLSchema#string

P407

P433

48

http://www.w3.org/2001/XMLSchema#string

P478

283

http://www.w3.org/2001/XMLSchema#string

P50

Shinji Hatakeyama

P577

2008-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18801741

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

2662271

http://www.w3.org/2001/XMLSchema#string